Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus
about
Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and ChallengesA contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virusSeroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010Two years after pandemic influenza A/2009/H1N1: what have we learned?Seroprevalence to influenza A(H1N1) 2009 virus--where are we?Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.Control of a Reassortant Pandemic 2009 H1N1 Influenza Virus Outbreak in an Intensive Swine Breeding Farm: Effect of Vaccination and Enhanced Farm Management Practices.Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets.Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice.Swine outbreak of pandemic influenza A virus on a Canadian research farm supports human-to-swine transmissionMF59 adjuvant: the best insurance against influenza strain diversity.Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2.Pandemic influenza: certain uncertainties.Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus.No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodiesRevisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.Boosting heterosubtypic neutralization antibodies in recipients of 2009 pandemic H1N1 influenza vaccine.Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.Effect of priming with H1N1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic H1N1 virus.1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humansNeutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination2009 A(H1N1) seroconversion rates and risk factors among the general population in Vientiane Capital, Laos.A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model.Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore.Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 studyImmunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infectionInfluenza vaccines: from whole virus preparations to recombinant protein technology.Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera.Humoral immune responses during asthma and influenza co-morbidity in mice.The antigenic evolution of influenza: drift or thrift?Seroprevalence of pandemic influenza viruses, New York, New York, USA, 2004.Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic.The Role and Molecular Mechanism of Action of Surfactant Protein D in Innate Host Defense Against Influenza A Virus.Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial
P2860
Q26783884-3CBA5B87-F0E3-4758-B42F-D4C90571215DQ27316330-AFA64B4E-F941-4AC0-B480-41D68AB1544EQ28742786-68995822-F332-498E-9A9F-47A633F4D688Q30224656-ABA88C1E-BE6A-48CF-9DC8-BE13ED06267CQ30226546-8C706616-40F6-4C89-ACD4-5C247B98C0FDQ30352862-9F4AB55C-BB09-47B5-9E7B-6F0894F9EF16Q30366806-B9BFC5AA-A4BE-44ED-9E4A-DDF9B1E15404Q30374307-80F23222-80B1-4547-963C-5FE828D79D77Q30394606-E70AD5D9-3AD8-490E-9EB0-91058A69498DQ30394731-D316E5D1-81D9-4057-932D-F261A4657294Q30397261-3696BE92-3414-4FA5-966A-13ED621FF43BQ30402018-857964BB-29D8-4431-9E0B-02AB3B93E07FQ30404095-2758BB4C-6BE6-40CC-A4D6-935EAFAAFE76Q30404256-815C7233-D999-48E5-B806-1B4D3151F87FQ30404512-AFF3C881-CBD6-4247-944E-E54DECF8F3A9Q30407561-1A865BF5-A8E9-4162-B4CA-7C5846AC9759Q30407834-E07E6379-9819-4A90-882A-467F0D8A5156Q30408974-A5E21E6F-5FA8-4D5A-83D4-E1AD97BEF47CQ30413677-486CDF16-A0E7-4024-8ADA-BBFDE447E3BFQ30417675-29D92779-8CF6-45E7-B09F-32EBA5ED020BQ30422641-F82B1431-C63D-436B-95E3-E152579B0A33Q30423166-DF5C2FDB-1770-48A9-9D98-4BD74F0BD2FDQ30429248-F95257AC-3018-4CCB-A293-69022AE5016FQ30430052-87B4B461-58E3-4730-B8D4-36D16081F7C2Q35474243-30D9EAA8-F7F5-4BD0-9E0B-4976777FF466Q36570810-086FF3B3-F190-4816-AFF4-ED28F7386022Q36621905-35ED7911-9CA3-4DFA-B7F1-9A10D5782D00Q36984193-E2892787-39B2-4146-9D7A-933CB2628928Q38160083-5B49AE6D-1F0E-44D4-BD86-6C02BED1885AQ39215322-72660A3C-D4E2-4310-8C19-9557B86C52D1Q40048919-68DC03E9-F99C-469E-A076-2C999899DF37Q42148563-C6E98D5F-57EE-4459-B282-386EBCE3A515Q43077597-E203FDCB-8765-4D1A-B998-6E598C7B6B3FQ47552843-393CB7ED-A38D-40D7-871A-D52A70DFD5FEQ55397297-04C0379A-7F12-45A2-9A28-C6011BBF8F9CQ56562454-ABB98DDB-1A11-4886-B979-DD1E76AE003E
P2860
Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Recipients of vaccine against ...... 009 novel H1N1 influenza virus
@ast
Recipients of vaccine against ...... 009 novel H1N1 influenza virus
@en
Recipients of vaccine against ...... 009 novel H1N1 influenza virus
@nl
type
label
Recipients of vaccine against ...... 009 novel H1N1 influenza virus
@ast
Recipients of vaccine against ...... 009 novel H1N1 influenza virus
@en
Recipients of vaccine against ...... 009 novel H1N1 influenza virus
@nl
prefLabel
Recipients of vaccine against ...... 009 novel H1N1 influenza virus
@ast
Recipients of vaccine against ...... 009 novel H1N1 influenza virus
@en
Recipients of vaccine against ...... 009 novel H1N1 influenza virus
@nl
P2093
P2860
P356
P1476
Recipients of vaccine against ...... 009 novel H1N1 influenza virus
@en
P2093
Kim J Allison
Kristen C Branum
Lee-Ann Van De Velde
Patricia M Flynn
P2860
P304
P356
10.1086/652441
P407
P577
2010-06-01T00:00:00Z